Expect a priced offering announcement within 1-2 days. The dilutive overhang will pressure the stock until the offering terms (size, price, discount) are disclosed. Traders should watch for the prospectus (424B4) for exact share count and price; any discount to market will accelerate selling. Given the micro-cap status, the offering may be structured as a registered direct or at-the-market (ATM) facility.
CRIS drugs
CRIS drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 13 $1.87entry
- T+1 · 3mo ago −3.74%α −3.55% · $1.80
- T+5 · 3mo ago −13.90%α −11.94% · $1.61
- T+20 · 2mo ago −39.57%α −37.83% · $1.13
- T+60 · 11d ago −51.52%α −46.05% · $0.9065
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Curis Inc.'s S-1 registration statement (File No. 333-298203) was declared effective by the SEC on August 12, 2026, under the 1933 Act. This allows the company to proceed with a securities offering, which for a micro-cap biotech with a $5M market cap is likely a dilutive follow-on or at-the-market offering. The effectiveness creates immediate dilution overhang for existing common shareholders, as the company can now sell shares to raise capital.
Key Facts
- SEC declared effective Curis Inc.'s S-1 registration statement (File No. 333-298203) on August 12, 2026.
- The effectiveness allows Curis to sell securities under the 1933 Act, typically a dilutive follow-on offering for a micro-cap biotech.
- Curis has a market capitalization of approximately $5M, making any new share issuance materially dilutive.
- The company is a clinical-stage biotech (SIC 2836) with no disclosed revenue or product sales in the filing.
Financial Impact
Undisclosed amount; the S-1 registration does not specify the size or price of the offering. Given the $5M market cap, even a modest offering (e.g., $1-2M) would be highly dilutive to existing shareholders.
Risk Factors
- Immediate dilution from new share issuance could depress stock price by 10-30% depending on offering size and discount.
- No disclosed use of proceeds or business update, the offering may signal cash burn concerns and a need for emergency capital.
- Micro-cap biotech with $5M market cap faces high delisting risk if Nasdaq minimum bid price or market value requirements are not met.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002653 |
| Document: 9999999995-26-002653-index.html | 9999999995-26-002653 |
| Document: 9999999995-26-002653.txt | 9999999995-26-002653 |
Track record
18 reports on CRIS
6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
- Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
- Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
- Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers